Lifestyle Modification As Foundational Therapy In Diabetes: Reclaiming Its Role in the Era of New Pharmacotherapy

Abstract

Background: Type 2 Diabetes mellitus (T2D) represents one of the most significant global health challenges, with rapidly rising prevalence particularly in low- and middle-income countries. India is at the epicentre of this epidemic, with over 101 million adults currently living with diabetes. Accumulating evidence suggests that lifestyle factors—including diet, physical inactivity, obesity, sleep disruption, psychosocial stress, and addictive behaviors—play a central role in the development and progression of T2D. Despite advances in pharmacotherapy, lifestyle modification remains the most fundamental and cost-effective strategy for both prevention and management of diabetes. Objective: This narrative review aims to comprehensively evaluate the role of lifestyle modification in the prevention and management of T2D, integrating evidence across multiple domains including nutrition, physical activity, weight management, sleep and circadian health, stress and mental health, addictive behaviors, and emerging digital lifestyle tools. Methods: A narrative review of contemporary literature, including randomized controlled trials, observational studies, meta-analyses, and international guideline recommendations, was conducted to synthesize current evidence on lifestyle interventions influencing glycaemic control and cardiometabolic outcomes. Results: Evidence consistently demonstrates that structured lifestyle interventions significantly reduce the incidence of T2D and improve metabolic outcomes. Dietary approaches such as Mediterranean, vegetarian, and DASH diets improve glycaemic control, insulin sensitivity, and cardiovascular risk markers, whereas Western and ultra-processed food–rich diets increase diabetes risk. Regular physical activity—including aerobic, resistance, and high-intensity interval training—enhances insulin sensitivity and reduces HbA1c levels. Weight reduction of 5–10% through caloric restriction and behavioral support produces meaningful improvements in glycaemia and cardiometabolic health. Emerging therapies such as GLP-1–based pharmacotherapy, digital therapeutics, and microbiome interventions complement lifestyle interventions. Additionally, adequate sleep, circadian alignment, stress reduction strategies such as yoga and mindfulness, and avoidance of tobacco, alcohol, and substance abuse contribute to improved metabolic regulation and diabetes outcomes. Conclusion: Lifestyle modification remains the cornerstone of diabetes prevention and management, offering Lifestyle Modification As Foundational Therapy In Diabetes: Reclaiming Its Role in the Era of New Pharmacotherapy. multifaceted metabolic benefits that extend beyond glycaemic control. Integrated care models that combine structured lifestyle interventions with pharmacological therapy and digital health tools represent a promising strategy for addressing the growing diabetes burden, particularly in resourceconstrained settings such as India.